Last Name

Kevin W Chamberlin PharmD

TitleAssistant Clinical Professor
InstitutionUniversity of Connecticut
DepartmentPharmacy Practice
AddressUNIT 3092
Pharmacy/Bio, UNIT 3092
69 N Eagleville Road
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Ehret MJ, Chamberlin KW. Current Practices in the Treatment of Alzheimer Disease: Where is the Evidence After the Phase III Trials? Clin Ther. 2015 Aug; 37(8):1604-16. PMID: 26122885.
      View in: PubMed
    2. Chamberlin KW, Baker WL. Benefit-risk assessment of pitavastatin for the treatment of hypercholesterolemia in older patients. Clin Interv Aging. 2015; 10:733-40. PMID: 25931816; PMCID: PMC4404990.
    3. Baker WL, Chamberlin KW. New oral anticoagulants vs. warfarin treatment: no need for pharmacogenomics? Clin Pharmacol Ther. 2014 Jul; 96(1):17-9. PMID: 24942397.
      View in: PubMed
    4. Baker WL, Smyth LR, Riche DM, Bourret EM, Chamberlin KW, White WB. Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: a systematic review and meta-analysis. J Am Soc Hypertens. 2014 Apr; 8(4):262-75.e9. PMID: 24602971.
      View in: PubMed
    5. Chamberlin KW, Silverman AR. Celecoxib-associated anaphylaxis. Ann Pharmacother. 2009 Apr; 43(4):777-81. PMID: 19299321.
      View in: PubMed
    6. Chamberlin KW, Cottle M, Neville R, Tan J. Oral oxymorphone for pain management. Ann Pharmacother. 2007 Jul; 41(7):1144-52. PMID: 17595308.
      View in: PubMed
    Chamberlin's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description
    Physical Neighbors Expand Description